RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Sabzali Javadov to Animals

This is a "connection" page, showing publications Sabzali Javadov has written about Animals.
Connection Strength

1.849
  1. Jang S, Javadov S. Unraveling the mechanisms of cardiolipin function: The role of oxidative polymerization of unsaturated acyl chains. Redox Biol. 2023 08; 64:102774.
    View in: PubMed
    Score: 0.073
  2. Jang S, Chapa-Dubocq XR, Parodi-Rull?n RM, Fossati S, Javadov S. Beta-Amyloid Instigates Dysfunction of Mitochondria in Cardiac Cells. Cells. 2022 01 22; 11(3).
    View in: PubMed
    Score: 0.067
  3. Javadov S, Jang S, Chapa-Dubocq XR, Khuchua Z, Camara AK. Mitochondrial respiratory supercomplexes in mammalian cells: structural versus functional role. J Mol Med (Berl). 2021 01; 99(1):57-73.
    View in: PubMed
    Score: 0.061
  4. Rodr?guez-Graciani KM, Chapa-Dubocq XR, MacMillan-Crow LA, Javadov S. Association Between L-OPA1 Cleavage and Cardiac Dysfunction During Ischemia-Reperfusion Injury in Rats. Cell Physiol Biochem. 2020 Oct 30; 54(6):1101-1114.
    View in: PubMed
    Score: 0.061
  5. Javadov S, Kozlov AV, Camara AKS. Mitochondria in Health and Diseases. Cells. 2020 05 09; 9(5).
    View in: PubMed
    Score: 0.059
  6. Chapa-Dubocq XR, Rodr?guez-Graciani KM, Guzm?n-Hern?ndez RA, Jang S, Brookes PS, Javadov S. Cardiac Function is not Susceptible to Moderate Disassembly of Mitochondrial Respiratory Supercomplexes. Int J Mol Sci. 2020 Feb 25; 21(5).
    View in: PubMed
    Score: 0.058
  7. Jang S, Javadov S. OPA1 regulates respiratory supercomplexes assembly: The role of mitochondrial swelling. Mitochondrion. 2020 03; 51:30-39.
    View in: PubMed
    Score: 0.058
  8. Makarov VI, Khmelinskii I, Khuchua Z, Javadov S. In silico simulation of reversible and irreversible swelling of mitochondria: The role of membrane rigidity. Mitochondrion. 2020 01; 50:71-81.
    View in: PubMed
    Score: 0.057
  9. M Parodi-Rull?n R, Chapa-Dubocq X, Guzm?n-Hern?ndez R, Jang S, A Torres-Ramos C, Ayala-Pe?a S, Javadov S. The Role of Adenine Nucleotide Translocase in the Assembly of Respiratory Supercomplexes in Cardiac Cells. Cells. 2019 10 13; 8(10).
    View in: PubMed
    Score: 0.057
  10. Escobales N, Nu?ez RE, Javadov S. Mitochondrial angiotensin receptors and cardioprotective pathways. Am J Physiol Heart Circ Physiol. 2019 06 01; 316(6):H1426-H1438.
    View in: PubMed
    Score: 0.055
  11. Jang S, Javadov S. Elucidating the contribution of ETC complexes I and II to the respirasome formation in cardiac mitochondria. Sci Rep. 2018 12 07; 8(1):17732.
    View in: PubMed
    Score: 0.054
  12. Khuchua Z, Glukhov AI, Strauss AW, Javadov S. Elucidating the Beneficial Role of PPAR Agonists in Cardiac Diseases. Int J Mol Sci. 2018 Nov 04; 19(11).
    View in: PubMed
    Score: 0.053
  13. Parodi-Rull?n RM, Soto-Prado J, Vega-Lugo J, Chapa-Dubocq X, D?az-Cordero SI, Javadov S. Divergent Effects of Cyclophilin-D Inhibition on the Female Rat Heart: Acute Versus Chronic Post-Myocardial Infarction. Cell Physiol Biochem. 2018; 50(1):288-303.
    View in: PubMed
    Score: 0.053
  14. Chapa-Dubocq X, Makarov V, Javadov S. Simple kinetic model of mitochondrial swelling in cardiac cells. J Cell Physiol. 2018 07; 233(7):5310-5321.
    View in: PubMed
    Score: 0.050
  15. Jang S, Javadov S. Association between ROS production, swelling and the respirasome integrity in cardiac mitochondria. Arch Biochem Biophys. 2017 09 15; 630:1-8.
    View in: PubMed
    Score: 0.049
  16. Javadov S, Jang S, Parodi-Rull?n R, Khuchua Z, Kuznetsov AV. Mitochondrial permeability transition in cardiac ischemia-reperfusion: whether cyclophilin D is a viable target for cardioprotection? Cell Mol Life Sci. 2017 08; 74(15):2795-2813.
    View in: PubMed
    Score: 0.048
  17. Jang S, Lewis TS, Powers C, Khuchua Z, Baines CP, Wipf P, Javadov S. Elucidating Mitochondrial Electron Transport Chain Supercomplexes in the Heart During Ischemia-Reperfusion. Antioxid Redox Signal. 2017 07 01; 27(1):57-69.
    View in: PubMed
    Score: 0.046
  18. Javadov S, Jang S, Rodriguez-Reyes N, Rodriguez-Zayas AE, Soto Hernandez J, Krainz T, Wipf P, Frontera W. Mitochondria-targeted antioxidant preserves contractile properties and mitochondrial function of skeletal muscle in aged rats. Oncotarget. 2015 Nov 24; 6(37):39469-81.
    View in: PubMed
    Score: 0.043
  19. Barreto-Torres G, Hernandez JS, Jang S, Rodr?guez-Mu?oz AR, Torres-Ramos CA, Basnakian AG, Javadov S. The beneficial effects of AMP kinase activation against oxidative stress are associated with prevention of PPARa-cyclophilin D interaction in cardiomyocytes. Am J Physiol Heart Circ Physiol. 2015 Apr 01; 308(7):H749-58.
    View in: PubMed
    Score: 0.041
  20. Javadov S, Escobales N. The Role of SIRT3 in Mediating Cardioprotective Effects of RAS Inhibition on Cardiac Ischemia-Reperfusion. J Pharm Pharm Sci. 2015; 18(3):547-50.
    View in: PubMed
    Score: 0.041
  21. Jang S, Javadov S. Inhibition of JNK aggravates the recovery of rat hearts after global ischemia: the role of mitochondrial JNK. PLoS One. 2014; 9(11):e113526.
    View in: PubMed
    Score: 0.041
  22. Escobales N, Nu?ez RE, Jang S, Parodi-Rullan R, Ayala-Pe?a S, Sacher JR, Skoda EM, Wipf P, Frontera W, Javadov S. Mitochondria-targeted ROS scavenger improves post-ischemic recovery of cardiac function and attenuates mitochondrial abnormalities in aged rats. J Mol Cell Cardiol. 2014 Dec; 77:136-46.
    View in: PubMed
    Score: 0.040
  23. Javadov S. Letter to the editor: "cyclosporin A in left ventricular remodeling after myocardial infarction". Am J Physiol Heart Circ Physiol. 2014 Mar 01; 306(5):H777.
    View in: PubMed
    Score: 0.038
  24. Hern?ndez JS, Barreto-Torres G, Kuznetsov AV, Khuchua Z, Javadov S. Crosstalk between AMPK activation and angiotensin II-induced hypertrophy in cardiomyocytes: the role of mitochondria. J Cell Mol Med. 2014 Apr; 18(4):709-20.
    View in: PubMed
    Score: 0.038
  25. Barreto-Torres G, Parodi-Rull?n R, Javadov S. The role of PPARa in metformin-induced attenuation of mitochondrial dysfunction in acute cardiac ischemia/reperfusion in rats. Int J Mol Sci. 2012; 13(6):7694-7709.
    View in: PubMed
    Score: 0.034
  26. Parodi-Rullan R, Barreto-Torres G, Ruiz L, Casasnovas J, Javadov S. Direct renin inhibition exerts an anti-hypertrophic effect associated with improved mitochondrial function in post-infarction heart failure in diabetic rats. Cell Physiol Biochem. 2012; 29(5-6):841-50.
    View in: PubMed
    Score: 0.034
  27. Javadov S, Rajapurohitam V, Kilic A, Hunter JC, Zeidan A, Said Faruq N, Escobales N, Karmazyn M. Expression of mitochondrial fusion-fission proteins during post-infarction remodeling: the effect of NHE-1 inhibition. Basic Res Cardiol. 2011 Jan; 106(1):99-109.
    View in: PubMed
    Score: 0.030
  28. Javadov S, Karmazyn M, Escobales N. Mitochondrial permeability transition pore opening as a promising therapeutic target in cardiac diseases. J Pharmacol Exp Ther. 2009 Sep; 330(3):670-8.
    View in: PubMed
    Score: 0.028
  29. Javadov S, Rajapurohitam V, Kilic A, Zeidan A, Choi A, Karmazyn M. Anti-hypertrophic effect of NHE-1 inhibition involves GSK-3beta-dependent attenuation of mitochondrial dysfunction. J Mol Cell Cardiol. 2009 Jun; 46(6):998-1007.
    View in: PubMed
    Score: 0.027
  30. Karmazyn M, Kilic A, Javadov S. The role of NHE-1 in myocardial hypertrophy and remodelling. J Mol Cell Cardiol. 2008 Apr; 44(4):647-53.
    View in: PubMed
    Score: 0.025
  31. Javadov S, Choi A, Rajapurohitam V, Zeidan A, Basnakian AG, Karmazyn M. NHE-1 inhibition-induced cardioprotection against ischaemia/reperfusion is associated with attenuation of the mitochondrial permeability transition. Cardiovasc Res. 2008 Jan 15; 77(2):416-24.
    View in: PubMed
    Score: 0.025
  32. Javadov S, Karmazyn M. Mitochondrial permeability transition pore opening as an endpoint to initiate cell death and as a putative target for cardioprotection. Cell Physiol Biochem. 2007; 20(1-4):1-22.
    View in: PubMed
    Score: 0.023
  33. Javadov S, Purdham DM, Zeidan A, Karmazyn M. NHE-1 inhibition improves cardiac mitochondrial function through regulation of mitochondrial biogenesis during postinfarction remodeling. Am J Physiol Heart Circ Physiol. 2006 Oct; 291(4):H1722-30.
    View in: PubMed
    Score: 0.022
  34. Javadov S, Baetz D, Rajapurohitam V, Zeidan A, Kirshenbaum LA, Karmazyn M. Antihypertrophic effect of Na+/H+ exchanger isoform 1 inhibition is mediated by reduced mitogen-activated protein kinase activation secondary to improved mitochondrial integrity and decreased generation of mitochondrial-derived reactive oxygen species. J Pharmacol Exp Ther. 2006 Jun; 317(3):1036-43.
    View in: PubMed
    Score: 0.022
  35. Javadov S, Huang C, Kirshenbaum L, Karmazyn M. NHE-1 inhibition improves impaired mitochondrial permeability transition and respiratory function during postinfarction remodelling in the rat. J Mol Cell Cardiol. 2005 Jan; 38(1):135-43.
    View in: PubMed
    Score: 0.020
  36. Javadov SA, Clarke S, Das M, Griffiths EJ, Lim KH, Halestrap AP. Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart. J Physiol. 2003 Jun 01; 549(Pt 2):513-24.
    View in: PubMed
    Score: 0.018
  37. Kuznetsov AV, Javadov S, Margreiter R, Hagenbuchner J, Ausserlechner MJ. Analysis of Mitochondrial Function, Structure, and Intracellular Organization In Situ in Cardiomyocytes and Skeletal Muscles. Int J Mol Sci. 2022 Feb 18; 23(4).
    View in: PubMed
    Score: 0.017
  38. Parodi-Rull?n RM, Javadov S, Fossati S. Dissecting the Crosstalk between Endothelial Mitochondrial Damage, Vascular Inflammation, and Neurodegeneration in Cerebral Amyloid Angiopathy and Alzheimer's Disease. Cells. 2021 10 27; 10(11).
    View in: PubMed
    Score: 0.016
  39. Sparvero LJ, Tian H, Amoscato AA, Sun WY, Anthonymuthu TS, Tyurina YY, Kapralov O, Javadov S, He RR, Watkins SC, Winograd N, Kagan VE, Bayir H. Direct Mapping of Phospholipid Ferroptotic Death Signals in Cells and Tissues by Gas Cluster Ion Beam Secondary Ion Mass Spectrometry (GCIB-SIMS). Angew Chem Int Ed Engl. 2021 05 17; 60(21):11784-11788.
    View in: PubMed
    Score: 0.016
  40. Javadov SA, Lim KH, Kerr PM, Suleiman MS, Angelini GD, Halestrap AP. Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition. Cardiovasc Res. 2000 Jan 14; 45(2):360-9.
    View in: PubMed
    Score: 0.014
  41. Dzhavadov SA. [Relation between mitochondrial respiratory function and postischemic recovery of the isolated heart contractility]. Biull Eksp Biol Med. 1998 Nov; 126(11):538-41.
    View in: PubMed
    Score: 0.013
  42. Nu?ez RE, Javadov S, Escobales N. Critical role of angiotensin II type 2 receptors in the control of mitochondrial and cardiac function in angiotensin II-preconditioned rat hearts. Pflugers Arch. 2018 09; 470(9):1391-1403.
    View in: PubMed
    Score: 0.013
  43. Nu?ez RE, Javadov S, Escobales N. Angiotensin II-preconditioning is associated with increased PKCe/PKCd ratio and prosurvival kinases in mitochondria. Clin Exp Pharmacol Physiol. 2017 Dec; 44(12):1201-1212.
    View in: PubMed
    Score: 0.012
  44. Huang Y, Powers C, Moore V, Schafer C, Ren M, Phoon CK, James JF, Glukhov AV, Javadov S, Vaz FM, Jefferies JL, Strauss AW, Khuchua Z. The PPAR pan-agonist bezafibrate ameliorates cardiomyopathy in a mouse model of Barth syndrome. Orphanet J Rare Dis. 2017 03 09; 12(1):49.
    View in: PubMed
    Score: 0.012
  45. Rodr?Guez-Reyes N, Rodr?Guez-Zayas AE, Javadov S, Frontera WR. Single muscle fiber contractile properties in diabetic RAT muscle. Muscle Nerve. 2016 06; 53(6):958-64.
    View in: PubMed
    Score: 0.011
  46. Huang Y, Powers C, Madala SK, Greis KD, Haffey WD, Towbin JA, Purevjav E, Javadov S, Strauss AW, Khuchua Z. Cardiac metabolic pathways affected in the mouse model of barth syndrome. PLoS One. 2015; 10(6):e0128561.
    View in: PubMed
    Score: 0.010
  47. Zhdanov DD, Fahmi T, Wang X, Apostolov EO, Sokolov NN, Javadov S, Basnakian AG. Regulation of Apoptotic Endonucleases by EndoG. DNA Cell Biol. 2015 May; 34(5):316-26.
    View in: PubMed
    Score: 0.010
  48. Kuznetsov AV, Javadov S, Sickinger S, Frotschnig S, Grimm M. H9c2 and HL-1 cells demonstrate distinct features of energy metabolism, mitochondrial function and sensitivity to hypoxia-reoxygenation. Biochim Biophys Acta. 2015 Feb; 1853(2):276-84.
    View in: PubMed
    Score: 0.010
  49. Nu?ez RE, Castro M, Javadov S, Escobales N. Angiotensin II and ischemic preconditioning synergize to improve mitochondrial function while showing additive effects on ventricular postischemic recovery. J Cardiovasc Pharmacol. 2014 Aug; 64(2):172-9.
    View in: PubMed
    Score: 0.010
  50. Xiong D, He H, James J, Tokunaga C, Powers C, Huang Y, Osinska H, Towbin JA, Purevjav E, Balschi JA, Javadov S, McGowan FX, Strauss AW, Khuchua Z. Cardiac-specific VLCAD deficiency induces dilated cardiomyopathy and cold intolerance. Am J Physiol Heart Circ Physiol. 2014 Feb; 306(3):H326-38.
    View in: PubMed
    Score: 0.009
  51. Rajapurohitam V, Kilic A, Javadov S, Karmazyn M. Role of NF-?B and p38 MAPK activation in mediating angiotensin II and endothelin-1-induced stimulation in leptin production and cardiomyocyte hypertrophy. Mol Cell Biochem. 2012 Jul; 366(1-2):287-97.
    View in: PubMed
    Score: 0.008
  52. Gan XT, Hunter JC, Huang C, Xue J, Rajapurohitam V, Javadov S, Karmazyn M. Ouabain increases iNOS-dependent nitric oxide generation which contributes to the hypertrophic effect of the glycoside: possible role of peroxynitrite formation. Mol Cell Biochem. 2012 Apr; 363(1-2):323-33.
    View in: PubMed
    Score: 0.008
  53. Zeidan A, Hunter JC, Javadov S, Karmazyn M. mTOR mediates RhoA-dependent leptin-induced cardiomyocyte hypertrophy. Mol Cell Biochem. 2011 Jun; 352(1-2):99-108.
    View in: PubMed
    Score: 0.008
  54. Hunter JC, Zeidan A, Javadov S, Kilic A, Rajapurohitam V, Karmazyn M. Nitric oxide inhibits endothelin-1-induced neonatal cardiomyocyte hypertrophy via a RhoA-ROCK-dependent pathway. J Mol Cell Cardiol. 2009 Dec; 47(6):810-8.
    View in: PubMed
    Score: 0.007
  55. Kilic A, Javadov S, Karmazyn M. Estrogen exerts concentration-dependent pro-and anti-hypertrophic effects on adult cultured ventricular myocytes. Role of NHE-1 in estrogen-induced hypertrophy. J Mol Cell Cardiol. 2009 Mar; 46(3):360-9.
    View in: PubMed
    Score: 0.007
  56. Sharov VG, Saks VA, Kupriyanov VV, Lakomkin VL, Kapelko VI, Javadov SA. Protection of ischemic myocardium by exogenous phosphocreatine. I. Morphologic and phosphorus 31-nuclear magnetic resonance studies. J Thorac Cardiovasc Surg. 1987 Nov; 94(5):749-61.
    View in: PubMed
    Score: 0.006
  57. Zeidan A, Javadov S, Chakrabarti S, Karmazyn M. Leptin-induced cardiomyocyte hypertrophy involves selective caveolae and RhoA/ROCK-dependent p38 MAPK translocation to nuclei. Cardiovasc Res. 2008 Jan; 77(1):64-72.
    View in: PubMed
    Score: 0.006
  58. Zeidan A, Paylor B, Steinhoff KJ, Javadov S, Rajapurohitam V, Chakrabarti S, Karmazyn M. Actin cytoskeleton dynamics promotes leptin-induced vascular smooth muscle hypertrophy via RhoA/ROCK- and phosphatidylinositol 3-kinase/protein kinase B-dependent pathways. J Pharmacol Exp Ther. 2007 Sep; 322(3):1110-6.
    View in: PubMed
    Score: 0.006
  59. Xia Y, Javadov S, Gan TX, Pang T, Cook MA, Karmazyn M. Distinct KATP channels mediate the antihypertrophic effects of adenosine receptor activation in neonatal rat ventricular myocytes. J Pharmacol Exp Ther. 2007 Jan; 320(1):14-21.
    View in: PubMed
    Score: 0.006
  60. Zeidan A, Javadov S, Karmazyn M. Essential role of Rho/ROCK-dependent processes and actin dynamics in mediating leptin-induced hypertrophy in rat neonatal ventricular myocytes. Cardiovasc Res. 2006 Oct 01; 72(1):101-11.
    View in: PubMed
    Score: 0.006
  61. Rajapurohitam V, Javadov S, Purdham DM, Kirshenbaum LA, Karmazyn M. An autocrine role for leptin in mediating the cardiomyocyte hypertrophic effects of angiotensin II and endothelin-1. J Mol Cell Cardiol. 2006 Aug; 41(2):265-74.
    View in: PubMed
    Score: 0.006
  62. Zeidan A, Purdham DM, Rajapurohitam V, Javadov S, Chakrabarti S, Karmazyn M. Leptin induces vascular smooth muscle cell hypertrophy through angiotensin II- and endothelin-1-dependent mechanisms and mediates stretch-induced hypertrophy. J Pharmacol Exp Ther. 2005 Dec; 315(3):1075-84.
    View in: PubMed
    Score: 0.005
  63. Lebedeva LG, Aleksandrova SS, Kiselar' ZhG, Kirsanova ID, Dzhavadov SA, Basnak'ian AG, Votrin II. [Study of the spectrum of rabbit myocardium nuclear DNAases using models of ischemia and diabetes mellitus]. Vopr Med Khim. 1995 Jul-Aug; 41(4):2-4.
    View in: PubMed
    Score: 0.005
  64. Lebedeva LG, Aleksandrova SS, Kirsanova ID, Basnak'ian AG, Dzhavadov SA, Votrin II. [Nuclear endo-DNAse from rabbit myocardium in ischemia and diabetes mellitus]. Vopr Med Khim. 1995 May-Jun; 41(3):9-11.
    View in: PubMed
    Score: 0.005
  65. Lim KH, Javadov SA, Das M, Clarke SJ, Suleiman MS, Halestrap AP. The effects of ischaemic preconditioning, diazoxide and 5-hydroxydecanoate on rat heart mitochondrial volume and respiration. J Physiol. 2002 12 15; 545(3):961-74.
    View in: PubMed
    Score: 0.004
  66. Dzhavadov SA, Dzhokharidze TZ, Dzhaliashvili IV, Gel'fgat EB, Saks VA, Pogacha G. [Energy metabolism and contractile function of the heart in diabetic cardiomyopathy: effect of ischemia and reperfusion]. Biokhimiia. 1992 Dec; 57(12):1917-29.
    View in: PubMed
    Score: 0.004
  67. Kuznetsov AV, Veksler VI, Sharov VG, Dzhavadov SA, Saks VA. [Quantitative relationship between ischemic heart disease and parameters of energy metabolism]. Vestn Ross Akad Med Nauk. 1992; (3):21-6.
    View in: PubMed
    Score: 0.004
  68. Halestrap AP, Kerr PM, Javadov S, Woodfield KY. Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury of the heart. Biochim Biophys Acta. 1998 Aug 10; 1366(1-2):79-94.
    View in: PubMed
    Score: 0.003
  69. Seppet EK, Kallikorm AP, Dzhavadov SA, Preobrazhenskii AN, Lakomkin VA. [Energy-related disorders of myocardial contractility in calcium overload of the cardiomyocytes]. Kardiologiia. 1987 Jul; 27(7):72-6.
    View in: PubMed
    Score: 0.003
  70. Preobrazhenskii AN, Dzhavadov SA, Saks VA. [Possible mechanism of the protective effect of phosphocreatine on the ischemic myocardium]. Biokhimiia. 1986 Apr; 51(4):675-83.
    View in: PubMed
    Score: 0.003
  71. Dzhavadov SA, Preobrazhenskii AN, Saks VA. [Effect of phosphocreatine on the lysophosphoglyceride levels in total ischemia of the rat myocardium]. Biokhimiia. 1986 Apr; 51(4):668-74.
    View in: PubMed
    Score: 0.003
  72. Dzhavadov SA, Preobrazhenskii AN, Lakomkin VL, Kupriianov VV, Saks VA. [Various aspects of protective effect of exogenous phosphocreatine on the ischemic myocardium]. Vestn Akad Med Nauk SSSR. 1986; (12):58-67.
    View in: PubMed
    Score: 0.003
  73. Aniukhovskii EP, Dzhavadov SA, Preobrazhenskii AN, Beloshapko GG, Rozenshtraukh LV. [Effect of phosphocreatine and phosphocreatinine on membrane phospholipid metabolism in acute myocardial ischemia]. Kardiologiia. 1985 Aug; 25(8):64-8.
    View in: PubMed
    Score: 0.003
  74. Saks VA, Kapelko VI, Kupriyanov VV, Kuznetsov AV, Lakomkin VL, Veksler VI, Sharov VG, Javadov SA, Seppet EK, Kairane C. Quantitative evaluation of relationship between cardiac energy metabolism and post-ischemic recovery of contractile function. J Mol Cell Cardiol. 1989 Feb; 21 Suppl 1:67-78.
    View in: PubMed
    Score: 0.002
  75. Anyukhovsky EP, Javadov SA, Preobrazhensky AN, Beloshapko GG, Rosenshtraukh LV, Saks VA. Effect of phosphocreatine and related compounds on the phospholipid metabolism of ischemic heart. Biochem Med Metab Biol. 1986 Jun; 35(3):327-34.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support